The DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Increased metabolic vulnerability in early-onset Alzheimer’s disease is not related to amyloid burden
Open accessAbstract
Patients with early age-of-onset Alzheimer's disease show more rapid progression, more generalized cognitive deficits and greater cortical atrophy and hypometabolism compared to late-onset patients at a similar disease stage. The biological mechanisms that underlie these differences are not well understood. The purpose of this study was to examine in vivo whether metabolic differences between early-onset and late-onset Alzheimer's disease are associated with differences in the distribution and burden of fibrillar amyloid-beta. Patients meeting criteria for probable Alzheimer's disease (National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's; Disease and Related Disorders Association criteria) were divided based on estimated age at first symptom (less than or greater than 65 years) into early-onset (n = 21, mean age-at-onset 55.2 +/- 5.9 years) and late-onset (n = 18, 72.0 +/- 4.7 years) groups matched for disease duration and severity. Patients underwent positron emission tomography with the amyloid-beta-ligand [(11)C]-labelled Pittsburgh compound-B and the glucose analogue [(18)F]-labelled fluorodeoxyglucose. A group of cognitively normal controls (n = 30, mean age 73.7 +/- 6.4) was studied for comparison. [(11)C]-labelled Pittsburgh compound-B images were analysed using Logan graphical analysis (cerebellar reference) and [(18)F]-labelled fluorodeoxyglucose images were normalized to mean activity in the pons. Group differences in tracer uptake were assessed on a voxel-wise basis using statistical parametric mapping, and by comparing mean values in regions of interest. To account for brain atrophy, analyses were repeated after applying partial volume correction to positron emission tomography data. Compared to normal controls, both early-onset and late-onset Alzheimer's disease patient groups showed increased [(11)C]-labelled Pittsburgh compound-B uptake throughout frontal, parietal and lateral temporal cortices and striatum on voxel-wise and region of interest comparisons (P < 0.05). However, there were no significant differences in regional or global [(11)C]-labelled Pittsburgh compound-B binding between early-onset and late-onset patients. In contrast, early-onset patients showed significantly lower glucose metabolism than late-onset patients in precuneus/posterior cingulate, lateral temporo-parietal and occipital corticies (voxel-wise and region of interest comparisons, P < 0.05). Similar results were found for [(11)C]-labelled Pittsburgh compound-B and [(18)F]-labelled fluorodeoxyglucose using atrophy-corrected data. Age-at-onset correlated positively with glucose metabolism in precuneus, lateral parietal and occipital regions of interest (controlling for age, education and Mini Mental State Exam, P < 0.05), while no correlations were found between age-at-onset and [(11)C]-labelled Pittsburgh compound-B binding. In summary, a comparable burden of fibrillar amyloid-beta was associated with greater posterior cortical hypometabolism in early-onset Alzheimer's disease. Our data are consistent with a model in which both early amyloid-beta accumulation and increased vulnerability to amyloid-beta pathology play critical roles in the pathogenesis of Alzheimer's disease in young patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915
Tzourio-Mazoyer, N., Landeau, B., Papathanassiou, D., Crivello, F., Etard, O., Delcroix, N., Mazoyer, B., & Joliot, M. (2002) · NeuroImage · doi:10.1006/nimg.2001.0978 · Cited by 16,319
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B
Klunk, W. E., Engler, H., Nordberg, A., Wang, Y., Blomqvist, G., Holt, D. P., Bergström, M., Savitcheva, I., Huang, G., Estrada, S., et al. (2004) · Annals of Neurology · doi:10.1002/ana.20009 · Cited by 4,496
The Cardiovascular Health Study: design and rationale.
Fried, L. P., Borhani, N. O., Enright, P., Furberg, C. D., Gardin, J. M., Kronmal, R. A., Kuller, L. H., Manolio, T. A., Mittelmark, M. B., Newman, A., et al. (1991) · Annals of Epidemiology · doi:10.1016/1047-2797(91)90005-w · Cited by 3,652
Buckner, R. L., Sepulcre, J., Talukdar, T., Krienen, F. M., Liu, H., Hedden, T., Andrews-Hanna, J. R., Sperling, R. A., & Johnson, K. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.5062-08.2009 · Cited by 2,862
Consortium to Establish a Registry for Alzheimer's Disease (CERAD)
Fillenbaum, G. G., & Heyman, A. (2002) · Principles and Practice of Geriatric Psychiatry · doi:10.1002/0470846410.ch42(iii · Cited by 2,410
Resting-State Functional Connectivity Reflects Structural Connectivity in the Default Mode Network
Greicius, M. D., Supekar, K., Menon, V., & Dougherty, R. F. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhn059 · Cited by 2,175
Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., Sheline, Y. I., Klunk, W. E., Mathis, C. A., Morris, J. C., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.2177-05.2005 · Cited by 2,140
Mixed brain pathologies account for most dementia cases in community-dwelling older persons
Schneider, J. A., Arvanitakis, Z., Bang, W., & Bennett, D. A. (2007) · Neurology · doi:10.1212/01.wnl.0000271090.28148.24 · Cited by 1,992
Aβ Oligomers – a decade of discovery
Walsh, D. M., & Selkoe, D. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04426.x · Cited by 1,938
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Metabolic reduction in the posterior cingulate cortex in very early Alzheimer's disease
Minoshima, S., Giordani, B., Berent, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1997) · Annals of Neurology · doi:10.1002/ana.410420114 · Cited by 1,802
Parietal lobe contributions to episodic memory retrieval
Wagner, A. D., Shannon, B. J., Kahn, I., & Buckner, R. L. (2005) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2005.07.001 · Cited by 1,571
Longstreth, W. T., Manolio, T. A., Arnold, A., Burke, G. L., Bryan, N., Jungreis, C. A., Enright, P. L., O'Leary, D., & Fried, L. (1996) · Stroke · doi:10.1161/01.str.27.8.1274 · Cited by 1,464
The Clinical Diagnosis of Alzheimer's Disease
Wade, J. P. H., Mirsen, T. R., Hachinski, V. C., Fisman, M., Lau, C., & Merskey, H. (1987) · Archives of Neurology · doi:10.1001/archneur.1987.00520130016010 · Cited by 1,374
Reiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
The functional neuroanatomy of autobiographical memory: a meta-analysis
Svoboda, E., McKinnon, M. C., & Levine, B. (2006) · Neuropsychologia · doi:10.1016/j.neuropsychologia.2006.05.023 · Cited by 1,274
Synaptic Activity Regulates Interstitial Fluid Amyloid-β Levels In Vivo
Cirrito, J. R., Yamada, K. A., Finn, M. B., Sloviter, R. S., Bales, K. R., May, P. C., Schoepp, D. D., Paul, S. M., Mennerick, S., & Holtzman, D. M. (2005) · Neuron · doi:10.1016/j.neuron.2005.10.028 · Cited by 1,265
The prevalence of frontotemporal dementia
Ratnavalli, E., Brayne, C., Dawson, K., & Hodges, J. R. (2002) · Neurology · doi:10.1212/wnl.58.11.1615 · Cited by 1,157
Imaging β-amyloid burden in aging and dementia
Rowe, C. C., Ng, S., Ackermann, U., Gong, S. J., Pike, K., Savage, G., Cowie, T. F., Dickinson, K. L., Maruff, P., Darby, D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000261919.22630.ea · Cited by 1,104
Jack, C. R., Lowe, V. J., Weigand, S. D., Wiste, H. J., Senjem, M. L., Knopman, D. S., Shiung, M. M., Gunter, J. L., Boeve, B. F., Kemp, B. J., et al. (2009) · Brain · doi:10.1093/brain/awp062 · Cited by 1,099
Self-citation[ 11 C]PIB in a nondemented population: Potential antecedent marker of Alzheimer disease
Mintun, M. A., LaRossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., Klunk, W. E., Mathis, C. A., DeKosky, S. T., & Morris, J. C. (2006) · Neurology · doi:10.1212/01.wnl.0000228230.26044.a4 · Cited by 1,036
Sperling, R. A., LaViolette, P. S., O'Keefe, K., O'Brien, J., Rentz, D. M., Pihlajamaki, M., Marshall, G., Hyman, B. T., Selkoe, D. J., Hedden, T., et al. (2009) · Neuron · doi:10.1016/j.neuron.2009.07.003 · Cited by 1,027
Synthesis and Evaluation of 11C-Labeled 6-Substituted 2-Arylbenzothiazoles as Amyloid Imaging Agents
Mathis, C. A., Wang, Y., Holt, D. P., Huang, G.-F., Debnath, M. L., & Klunk, W. E. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030026b · Cited by 979
New stereological methods for counting neurons
West, M. J. (1993) · Neurobiology of Aging · doi:10.1016/0197-4580(93)90112-o · Cited by 940
Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer's disease
Ikonomovic, M. D., Klunk, W. E., Abrahamson, E. E., Mathis, C. A., Price, J. C., Tsopelas, N. D., Lopresti, B. J., Ziolko, S., Bi, W., Paljug, W. R., et al. (2008) · Brain · doi:10.1093/brain/awn016 · Cited by 933
Mahley, R. W., Weisgraber, K. H., & Huang, Y. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0600549103 · Cited by 912
Age, Neuropathology, and Dementia
Savva, G. M., Wharton, S. B., Ince, P. G., Forster, G., Matthews, F. E., & Brayne, C. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0806142 · Cited by 900
Patterns of brain atrophy in frontotemporal dementia and semantic dementia
Rosen, H. J., Gorno–Tempini, M. L., Goldman, W. P., Perry, R. J., Schuff, N., Weiner, M., Feiwell, R., Kramer, J. H., & Miller, B. L. (2002) · Neurology · doi:10.1212/wnl.58.2.198 · Cited by 841
Self-citationAPOE predicts amyloid‐beta but not tau Alzheimer pathology in cognitively normal aging
Morris, J. C., Roe, C. M., Xiong, C., Fagan, A. M., Goate, A. M., Holtzman, D. M., & Mintun, M. A. (2010) · Annals of Neurology · doi:10.1002/ana.21843 · Cited by 830
Reiman, E. M., Chen, K., Liu, X., Bandy, D., Yu, M., Lee, W., Ayutyanont, N., Keppler, J., Reeder, S. A., Langbaum, J. B. S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900345106 · Cited by 785
Kinetic Modeling of Amyloid Binding in Humans using PET Imaging and Pittsburgh Compound-B
Price, J. C., Klunk, W. E., Lopresti, B. J., Lu, X., Hoge, J. A., Ziolko, S. K., Holt, D. P., Meltzer, C. C., DeKosky, S. T., & Mathis, C. A. (2005) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600146 · Cited by 720
Episodic memory loss is related to hippocampal-mediated -amyloid deposition in elderly subjects
Mormino, E. C., Kluth, J. T., Madison, C. M., Rabinovici, G. D., Baker, S. L., Miller, B. L., Koeppe, R. A., Mathis, C. A., Weiner, M. W., Jagust, W. J., et al. (2009) · Brain · doi:10.1093/brain/awn320 · Cited by 684
Self-citationBerg, L., McKeel, D. W., Miller, J. P., Storandt, M., Rubin, E. H., Morris, J. C., Baty, J., Coats, M., Norton, J., Goate, A. M., et al. (1998) · Archives of Neurology · doi:10.1001/archneur.55.3.326 · Cited by 657
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A., Ringheim, A., Langstrom, B., & Nordberg, A. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 617
Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden
Hedden, T., Van Dijk, K. R. A., Becker, J. A., Mehta, A., Sperling, R. A., Johnson, K. A., & Buckner, R. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3189-09.2009 · Cited by 598
Sheline, Y. I., Raichle, M. E., Snyder, A. Z., Morris, J. C., Head, D., Wang, S., & Mintun, M. A. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.08.024 · Cited by 597
Liang, W. S., Reiman, E. M., Valla, J., Dunckley, T., Beach, T. G., Grover, A., Niedzielko, T. L., Schneider, L. E., Mastroeni, D., Caselli, R., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709259105 · Cited by 585
Lopresti, B. J., Klunk, W. E., Mathis, C. A., Hoge, J. A., Ziolko, S. K., Lu, X., MELTZER, C. C., Schimmel, K., Tsopelas, N. D., DeKosky, S. T., et al. (2005) · PubMed · Cited by 543
Amyloid, hypometabolism, and cognition in Alzheimer disease: An [11C]PIB and [18F]FDG PET study
Edison, P., Archer, H. A., Hinz, R., Hammers, A., Pavese, N., Tai, Y. F., Hotton, G., Cutler, D., Fox, N., Kennedy, A., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000244749.20056.d4 · Cited by 518
Kramer, J. H., Jurik, J., Sha, S. J., Rankin, K. P., Rosen, H. J., Johnson, J. K., & Miller, B. L. (2003) · Cognitive and Behavioral Neurology · doi:10.1097/00146965-200312000-00002 · Cited by 502
Self-citationThe topography of grey matter involvement in early and late onset Alzheimer's disease
Frisoni, G. B., Pievani, M., Testa, C., Sabattoli, F., Bresciani, L., Bonetti, M., Beltramello, A., Hayashi, K. M., Toga, A. W., & Thompson, P. M. (2007) · Brain · doi:10.1093/brain/awl377 · Cited by 435
Neurochemical characteristics of early and late onset types of Alzheimer's disease.
Rossor, M. N., Iversen, L. L., Reynolds, G. P., Mountjoy, C. Q., & Roth, M. (1984) · BMJ · doi:10.1136/bmj.288.6422.961 · Cited by 417
11 C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration
Rabinovici, G. D., Furst, A. J., O'Neil, J. P., Racine, C. A., Mormino, E. C., Baker, S. L., Chetty, S., Patel, P., Pagliaro, T. A., Klunk, W. E., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000259035.98480.ed · Cited by 410
Self-citationWhen less means more: deactivations during encoding that predict subsequent memory
Daselaar, S. M., Prince, S. E., & Cabeza, R. (2004) · NeuroImage · doi:10.1016/j.neuroimage.2004.07.031 · Cited by 388
Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer's disease
Gomez‐Isla, T., West, H. L., Rebeck, G. W., Harr, S. D., Growdon, J. H., Locascio, J. J., Perls, T. T., Lipsitz, L. A., & Hyman, B. T. (1996) · Annals of Neurology · doi:10.1002/ana.410390110 · Cited by 378
Seltzer, B. (1983) · Archives of Neurology · doi:10.1001/archneur.1983.04050030037006 · Cited by 365
MANN, D. M. A., YATES, P. O., & MARCYNIUK, B. (1984) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1984.tb00351.x · Cited by 345
Molecular Imaging With Pittsburgh Compound B Confirmed at Autopsy: A Case Report
Bacskai, B. J., Frosch, M. P., Freeman, S. H., Raymond, S. B., Augustinack, J. C., Johnson, K. A., Irizarry, M. C., Klunk, W. E., Mathis, C. A., DeKosky, S. T., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.3.431 · Cited by 341
Diffuse senile plaques occur commonly in the cerebellum in Alzheimer's disease.
Joachim, C. L., Morris, J. H., & Selkoe, D. J. (1989) · PubMed Central · Cited by 335
APOE genotype predicts when — not whether — one is predisposed to develop Alzheimer disease
Meyer, M. R., Tschanz, J. T., Norton, M. C., Welsh-Bohmer, K. A., Steffens, D. C., Wyse, B. W., & Breitner, J. C. S. (1998) · Nature Genetics · doi:10.1038/1206 · Cited by 334
Correction of PET Data for Partial Volume Effects in Human Cerebral Cortex by MR Imaging
Meltzer, C. C., Leal, J. P., Mayberg, H. S., Wagner, H. N., & Frost, J. J. (1990) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199007000-00011 · Cited by 329
Predictors of cognitive and functional progression in patients with probable Alzheimer's disease
Mortimer, J. A., Ebbitt, B., Jun, S.-P., & Finch, M. D. (1992) · Neurology · doi:10.1212/wnl.42.9.1689 · Cited by 323
Causative and susceptibility genes for Alzheimer’s disease: a review
Rocchi, A., Pellegrini, S., Siciliano, G., & Murri, L. (2003) · Brain Research Bulletin · doi:10.1016/s0361-9230(03)00067-4 · Cited by 316
Klunk, W. E., Wang, Y., Huang, G.-F., Debnath, M. L., Holt, D. P., Shao, L., Hamilton, R. L., Ikonomovic, M. D., DeKosky, S. T., & Mathis, C. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-06-02086.2003 · Cited by 309
PIB is a non-specific imaging marker of amyloid-beta (A ) peptide-related cerebral amyloidosis
Lockhart, A., Lamb, J. R., Osredkar, T., Sue, L. I., Joyce, J. N., Ye, L., Libri, V., Leppert, D., & Beach, T. G. (2007) · Brain · doi:10.1093/brain/awm191 · Cited by 302
Apolipoprotein E–dependent accumulation of Alzheimer disease–related lesions begins in middle age
Kok, E., Haikonen, S., Luoto, T., Huhtala, H., Goebeler, S., Haapasalo, H., & Karhunen, P. J. (2009) · Annals of Neurology · doi:10.1002/ana.21696 · Cited by 299
Precuneus atrophy in early-onset Alzheimer’s disease: a morphometric structural MRI study
Karas, G., Scheltens, P., Rombouts, S., van Schijndel, R., Klein, M., Jones, B., van der Flier, W., Vrenken, H., & Barkhof, F. (2007) · Neuroradiology · doi:10.1007/s00234-007-0269-2 · Cited by 295
Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., Albert, M., Brandt, J., & Stern, Y. (1994) · Neurology · doi:10.1212/wnl.44.7.1215 · Cited by 266
Cognitive Phenotypes in Alzheimer's Disease and Genetic Risk
Snowden, J. S., Stopford, C. L., Julien, C. L., Thompson, J. C., Davidson, Y., Gibbons, L., Pritchard, A., Lendon, C. L., Richardson, A. M., Varma, A., et al. (2007) · Cortex · doi:10.1016/s0010-9452(08)70683-x · Cited by 254
Comparative evaluation of MR-based partial-volume correction schemes for PET.
MELTZER, C. C., Kinahan, P. E., Greer, P. J., Nichols, T. E., Comtat, C., Cantwell, M. N., Lin, M., & Price, J. C. (1999) · PubMed · Cited by 254
Minoshima, S., Frey, K. A., Foster, N. L., & Kuhl, D. E. (1995) · Journal of Computer Assisted Tomography · doi:10.1097/00004728-199507000-00006 · Cited by 252 · cited 2×
“…disease and nine with late-onset Alzheimer’s disease) were scanned on a 1.5 Tesla Siemens VISION system (Rosen et al., 2002), and 11 patients (seven early-onset and fou late-onset) were scanned on a Bruker MedSpec 4 Tesla system controlled by a Siemens TrioTM console (Mueller et al., 2009).”
MethodInfluentialEffect of APOE genotype on amyloid plaque load and gray matter volume in Alzheimer disease
Drzezga, A., Grimmer, T., Henriksen, G., Mühlau, M., Perneczky, R., Miederer, I., Praus, C., Sorg, C., Wohlschläger, A., Riemenschneider, M., et al. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a2e8d0 · Cited by 248
Early‐onset Alzheimer's disease: Clinical predictors of institutionalization and death
Heyman, A., Wilkinson, W. E., Hurwitz, B. J., Helms, M. J., Haynes, C. S., Utley, C. M., & Gwyther, L. P. (1987) · Neurology · doi:10.1212/wnl.37.6.980 · Cited by 233
Kim, E. J., Cho, S. S., Jeong, Y., Park, K. C., Kang, S. J., Kang, E., Kim, S. E., Lee, K. H., & Na, D. L. (2005) · Brain · doi:10.1093/brain/awh539 · Cited by 232
Voxel-based analysis of PET amyloid ligand [ 11 C]PIB uptake in Alzheimer disease
Kemppainen, N. M., Aalto, S., Wilson, I. A., Någren, K., Helin, S., Brück, A., Oikonen, V., Kailajärvi, M., Scheinin, M., Viitanen, M., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000240117.55680.0a · Cited by 227
Bird, T. D., Stranahan, S., Sumi, S. M., & Raskind, M. (1983) · Annals of Neurology · doi:10.1002/ana.410140306 · Cited by 222
Leinonen, V. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.noc80013 · Cited by 199
Hansen, L. A., DeTeresa, R., Davies, P., & Terry, R. D. (1988) · Neurology · doi:10.1212/wnl.38.1.48 · Cited by 194
Ishii, K., Kawachi, T., Sasaki, H., Kono, A. K., Fukuda, T., KOJIMA, Y., & Mori, E. (2005) · PubMed · Cited by 193
Incidence of early-onset dementias in Cambridgeshire, United Kingdom
Mercy, L., Hodges, J. R., Dawson, K., Barker, R. A., & Brayne, C. (2008) · Neurology · doi:10.1212/01.wnl.0000334277.16896.fa · Cited by 189
Structural correlates of early and late onset Alzheimer's disease: voxel based morphometric study
Frisoni, G. B. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2003.029876 · Cited by 182
Agosta, F., Vossel, K. A., Miller, B. L., Migliaccio, R., Bonasera, S. J., Filippi, M., Boxer, A. L., Karydas, A., Possin, K. L., & Gorno-Tempini, M. L. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0812697106 · Cited by 178
Self-citationThe incidence of frontotemporal lobar degeneration in Rochester, Minnesota, 1990 through 1994
Knopman, D. S., Petersen, R. C., Edland, S. D., Cha, R. H., & Rocca, W. A. (2004) · Neurology · doi:10.1212/01.wnl.0000106827.39764.7e · Cited by 173
CSF biomarker levels in early and late onset Alzheimer's disease
Bouwman, F. H., Schoonenboom, N. S. M., Verwey, N. A., van Elk, E. J., Kok, A., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.02.007 · Cited by 168
Shiino, A., Watanabe, T., Maeda, K., Kotani, E., Akiguchi, I., & Matsuda, M. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.06.010 · Cited by 152
Koss, E., Edland, S., Fillenbaum, G., Mohs, R., Clark, C., Galasko, D., & Morris, J. C. (1996) · Neurology · doi:10.1212/wnl.46.1.136 · Cited by 150
Neuropsychologic Features of Early- and Late-Onset Alzheimer's Disease
Filley, C. M., Kelly, J., & Heaton, R. K. (1986) · Archives of Neurology · doi:10.1001/archneur.1986.00520060038014 · Cited by 149
Early-onset Alzheimer’s disease is associated with greater pathologic burden.
Marshall, G. A., Fairbanks, L. A., Tekin, S., Vinters, H. V., & Cummings, J. L. (2007) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/0891988706297086 · Cited by 143
Li, Y., Nowotny, P., Holmans, P., Smemo, S., Kauwe, J. S. K., Hinrichs, A. L., Tacey, K. M., Doil, L. M., van Luchene, R., Garcia, V., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403535101 · Cited by 140
Sakamoto, S., Ishii, K., Sasaki, M., Hosaka, K., Mori, T., Matsui, M., Hirono, N., & Mori, E. (2002) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(02)00114-4 · Cited by 139
Widespread neocortical abnormalities in temporal lobe epilepsy with and without mesial sclerosis
Mueller, S. G., Laxer, K. D., Barakos, J. A., Cheong, I., Garcia, P., & Weiner, M. W. (2009) · NeuroImage · doi:10.1016/j.neuroimage.2009.02.020 · Cited by 136
Self-citationKemp, P. M., Holmes, C., Hoffmann, S. M. A., Bolt, L., Holmes, R., Rowden, J., & Fleming, J. S. (2003) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.74.6.715 · Cited by 131
Farrer, L. A. (1997) · JAMA · doi:10.1001/jama.1997.03550160069041 · Cited by 124 · cited 7×
“M].”
BackgroundMethodResultInfluentialCerebral glucose metabolism in patients with AD and different APOE genotypes
Drzezga, A., Riemenschneider, M., Strassner, B., Grimmer, T., Peller, M., Knoll, A., Wagenpfeil, S., Minoshima, S., Schwaiger, M., & Kurz, A. (2005) · Neurology · doi:10.1212/01.wnl.0000148478.39691.d3 · Cited by 116
Factors associated with duration of survival in Alzheimer's disease
Barclay, L., Zemcov, A., Blass, J. P., & MCDOWELL, F. H. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90139-8 · Cited by 105
Grady, C. L., Haxby, J. V., Horwitz, B., Berg, G., & Рапопорт, С. И. (1987) · Neuropsychologia · doi:10.1016/0028-3932(87)90118-7 · Cited by 99
Bigio, E. H., Hynan, L. S., Sontag, E., Satumtira, S., & White, C. L. (2002) · Neuropathology and Applied Neurobiology · doi:10.1046/j.1365-2990.2002.00385.x · Cited by 93
Salmon, É., Collette, F., Degueldre, C., Lemaire, C. F., & Franck, G. (2000) · Human Brain Mapping · doi:10.1002/(sici)1097-0193(200005)10:1<39::aid-hbm50>3.0.co;2-b · Cited by 91
Deficient high-affinity binding of Pittsburgh compound B in a case of Alzheimer’s disease
Rosen, R. F., Ciliax, B. J., Wingo, T. S., Gearing, M., Dooyema, J. M., Lah, J. J., Ghiso, J. A., LeVine, H., & Walker, L. C. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0583-3 · Cited by 89
Age at Onset and Regional Cerebral Glucose Metabolism in Alzheimer’s Disease
Yasuno, F., Imamura, T., Hirono, N., Ishii, K., Sasaki, M., Ikejiri, Y., Hashimoto, M., Shimomura, T., Yamashita, H., & Mori, E. (1998) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000017024 · Cited by 74
Age at onset and visuocognitive disturbances in Alzheimer disease.
Fujimori, M., Imamura, T., Yamashita, H., Hirono, N., Ikejiri, Y., Shimomura, T., & Mori, E. (1998) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199809000-00007 · Cited by 72
Age at onset is associated with disease severity in Lewy body variant and Alzheimerʼs disease
Ho, G. J., Hansen, L. A., Alford, M. F., Foster, K., Salmon, D. P., Galasko, D. R., Thal, L. J., & Masliah, E. (2002) · Neuroreport · doi:10.1097/00001756-200210070-00028 · Cited by 72
Neuropsychological patterns of presenile and senile dementia of the Alzheimer type
Loring, D. W., & Largen, J. W. (1985) · Neuropsychologia · doi:10.1016/0028-3932(85)90021-1 · Cited by 70
Comparison of the severity of neuropathologic changes in familial and sporadic Alzheimer's disease.
Nochlin, D., van Belle, G., Bird, T. D., & Sumi, S. M. (1993) · PubMed · Cited by 66
Automated template-based PET region of interest analyses in the aging brain
Sun, F. T., Schriber, R. A., Greenia, J. M., He, J., Gitcho, A., & Jagust, W. J. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2006.09.022 · Cited by 58
Self-citationNeuropsychological Heterogeneity in Mild Alzheimer's Disease
Binetti, G. G., Magni, E., Padovani, A., Cappa, S. F., Bianchetti, A., & Trabucchi, M. (1993) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000107340 · Cited by 57
Jagust, W. J. (1990) · Archives of Neurology · doi:10.1001/archneur.1990.00530060036013 · Cited by 57
Self-citationAge at onset and language disturbances in Alzheimer’s disease
Imamura, T., Takatsuki, Y., Fujimori, M., Hirono, N., Ikejiri, Y., Shimomura, T., Hashimoto, M., Yamashita, H., & Mori, E. (1998) · Neuropsychologia · doi:10.1016/s0028-3932(98)00010-4 · Cited by 57
The effect of APOE ε4 allele on cerebral glucose metabolism in AD is a function of age at onset
Hirono, N., Hashimoto, M., Yasuda, M., Ishii, K., Sakamoto, S., Kazui, H., & Mori, E. (2002) · Neurology · doi:10.1212/wnl.58.5.743 · Cited by 42
Shiino, A., Watanabe, T., Kitagawa, T., Kotani, E., Takahashi, J., Morikawa, S., & Akiguchi, I. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000151241 · Cited by 39
A methodology for specifying PET VOIs using multimodality techniques
Klein, G. J., Teng, X., Jagust, W. J., Eberling, J. L., Acharya, A., Reutter, B. W., & Huesman, R. H. (1997) · IEEE Transactions on Medical Imaging · doi:10.1109/42.611350 · Cited by 32
Self-citation
Cited by
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer’s disease
Ossenkoppele, R., Schonhaut, D. R., Schöll, M., Lockhart, S. N., Ayakta, N., Baker, S. L., O’Neil, J. P., Janabi, M., Lazaris, A., Cantwell, A., et al. (2016) · Brain · doi:10.1093/brain/aww027 · Cited by 1,185
Self-citationBrain Imaging in Alzheimer Disease
Johnson, K. A., Fox, N. C., Sperling, R. A., & Klunk, W. E. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006213 · Cited by 875
Tau pathology and neurodegeneration contribute to cognitive impairment in Alzheimer’s disease
Bejanin, A., Schonhaut, D. R., La Joie, R., Kramer, J. H., Baker, S. L., Sosa, N., Ayakta, N., Cantwell, A., Janabi, M., Lauriola, M., et al. (2017) · Brain · doi:10.1093/brain/awx243 · Cited by 778
Self-citationErlandsson, K., Buvat, I., Pretorius, P. H., Thomas, B. A., & Hutton, B. F. (2012) · Physics in Medicine and Biology · doi:10.1088/0031-9155/57/21/r119 · Cited by 733
A network diffusion model of disease progression in dementia
Raj, A., Kuceyeski, A., & Weiner, M. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.040 · Cited by 723
Self-citation
Metadata
- Authors
- Rabinovici, G. D., Furst, A. J., Alkalay, A., Racine, C. A., O’Neil, J. P., Janabi, M., Baker, S. L., Agarwal, N., Bonasera, S. J., Mormino, E. C., Weiner, M. W., Gorno-Tempini, M. L., Rosen, H. J., Miller, B. L., & Jagust, W. J.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-01-15
- Volume
- 133
- Issue
- 2
- Pages
- 512-528
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2042795487
- Cited by
- 280
- References
- 105
- FWCI
- 15.75
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.